There were 2,122 press releases posted in the last 24 hours and 359,130 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Crossbow Therapeutics Selects First Development Candidate from its Portfolio of Next-Generation T-cell Engagers Directed at Intracellular Cancer Targets

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image